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We recently identified human P-selectin glycoprotein ligand-1 (PSGL-1) as a functional
enterovirus 71 (EV71) receptor and demonstrated PSGL-1-dependent replication for some EV71
strains in human leukocytes. Here, we report that four out of five PSGL-1-binding strains of EV71
replicated poorly in mouse L929 cells stably expressing human PSGL-1 (L-PSGL-1 cells).
Therefore, we compared the replication kinetics and entire genomic sequence of five original
EV71 strains and the corresponding EV71 variants (EV71-LPS), which were propagated once in
L-PSGL-1 cells. Direct sequence comparison of the entire genome of the original EV71 strains
and EV71-LPS variants identified several possible adaptive mutations during the course of
replication in L-PSGL-1 cells, including a putative determinant of the adaptive phenotype in
L-PSGL-1 cells at VP2-149. The results suggest that an adaptive mutation, along with a
PSGL-1-binding phenotype, may facilitate efficient PSGL-1-dependent replication of the EV71
strains in L-PSGL-1 cells.
Enterovirus 71 (EV71) is a small non-enveloped virus with
a ssRNA genome of about 7500 nt, and is a major causative
agent of hand, foot, and mouth disease. Hand, foot, and
mouth disease is usually a mild and self-limiting febrile
disease in children, but EV71 infection has been associated
with various neurological diseases such as aseptic men-
ingitis, polio-like paralysis and acute encephalitis with
neurological pulmonary oedema, mainly in young children
and infants (Chan et al., 2000; Ho et al., 1999; McMinn,
2002). Recently, EV71 outbreaks with a number of fatal
cases have been reported throughout the world, particu-
larly in the Asia–Pacific region, and the activity of EV71
infection remains a major public health threat (Yang et al.,
2009). Despite the importance of EV71, little is known
about the pathogenesis of severe neurological diseases
associated with EV71 at the molecular level.
Recently, we demonstrated that human P-selectin gly-
coprotein ligand-1 (PSGL-1) is one of the functional
receptors for EV71 (Nishimura et al., 2009). PSGL-1 is a
type I sialomucin membrane protein expressed mainly on
leukocytes (Laszik et al., 1996; Sako et al., 1993). PSGL-1
on leukocytes binds to selectins on the endothelium with
high affinity, and the interaction between PSGL-1 and
selectins mediates leukocyte rolling during the initial stage
of inflammatory cell recruitment to inflamed tissues.
On the other hand, Yamayoshi et al. (2009) identified
scavenger receptor class B member (SCARB2) as another
functional cellular receptor for EV71. SCARB2 is a type III
transmembrane protein with double-membrane anchoring
and cytoplasmic domains at N and C termini (Eskelinen
et al., 2003). Like the expression of PSGL-1, human
SCARB2 expression enables normally non-susceptible
mouse L929 cells to support viral replication and
development of EV71 induced cytopathic effects (CPE)
(Yamayoshi et al., 2009). All EV71 strains and the
prototype strain (G-10) of coxsackievirus A16 replicate in
L929 cells expressing human SCARB2 and in SCARB2-
positive RD cells in a SCARB2-dependent manner
(Yamayoshi et al., 2009). Previously examined EV71 strains
can be classified as PSGL-1-binding and PSGL-1-non-
binding strain (Nishimura et al., 2009).
To investigate the replication of various PSGL-1-binding
strains of EV71 in more detail, we established a mouse
L929 cell line that highly and stably expresses human
PSGL-1 on the cell surface (L-PSGL-1 cells) (Nishimura
et al., 2009). In the present study, we have shown that a
single passage of the original EV71 strains in L-PSGL-1
cells induced one or more amino acid substitutions
The GenBank/EMBL/DDBJ accession numbers for the sequences
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with the adaptive phenotype in these cells, and that the
substitution at VP2-K149I/M may be especially important.
We examined whether five PSGL-1-binding strains of EV71
(Table 1) induced CPE in L-PSGL-1 cells. The cells in 24-
well tissue culture trays (1610
5 cells) were infected with
EV71 [1610
6 50% cell culture infectious dose (CCID50)]
for 1 h at 34 uC. The cells were washed and cultured for
4 days at 34 uC. L-PSGL-1 cells exhibited CPE 4 days after
infection with the 1095 strain as reported previously (data
not shown) (Nishimura et al., 2009). However, four other
strains (75-Yamagata, SK-EV006, C7/Osaka and KED005)
did not induce significant CPE 4 days post-infection (data
not shown). Because we could immunofluorescently detect
a few cells that expressed the EV71 antigen in infected L-
PSGL-1 cells (data not shown), we attempted to propagate
original EV71 in L-PSGL-1 cells. The preparation of L-
PSGL-1-adapted EV71 variants (EV71-LPS) is summarized
in Supplementary Fig. S1 (available in JGV Online). L-
PSGL-1 cells (1610
6 cells) were inoculated with original
EV71 (1610
7 CCID50) for 1 h at 34 uC in a 10 cm dish.
Inoculated cells were then washed three times and
incubated in 10 ml medium at 34 uC. We incubated the
L-PSGL-1 cells until almost all cells showed CPE (about
10 days). Finally, we harvested the virus in the culture
supernatant and named it EV71-LPS. When we infected L-
PSGL-1 cells with EV71-LPS, all EV71 variants induced
apparent CPE within 4 days after inoculation (data not
shown). VP1 antigens were also detected in L-PSGL-1 cells
infected with all EV71-LPS variants (data not shown).
These observations indicated that EV71-LPS replicated well
in L-PSGL-1 cells.
Next, we infected L-PSGL-1 cells with EV71-LPS in the
presence of anti-human PSGL-1 mAb (KPL1; BD
Biosciences), which blocks EV71 binding to PSGL-1, as
described previously (Nishimura et al., 2009). Briefly, the
cells in 48-well tissue culture plates (4610
4 cells per well)
were infected with viruses of 4610
4 CCID50 for 1 h at
34 uC. We inoculated the cells with KED005 of 4610
3
CCID50, as we could not obtain sufficient viral titre for
KED005-LPS2. For mAb inhibition, we pretreated the cells
with 10 mgm l
21 mAb [KPL1 or isotype control (MOPC-
21; BioLegend)] for 1 h prior to infection, washed the cells,
and maintained them in medium with 10 mgm l
21 mAb.
At 4 days post-infection, the infected cells and super-
natants were freeze–thawed, and viral titres were deter-
mined by calculating CCID50 with a microtitration assay in
RD cells as described previously (Nagata et al., 2002). All
infection assays were carried out in triplicate, and the mean
viral titres were compared using Student’s t-test. P-values
,0.01 were considered statistically significant. As a PSGL-
1-negative control, we used L-bsd cells (L929 cells trans-
fected with an empty plasmid and selected in the presence
of blasticidin) (Nishimura et al., 2009).
The original 1095 strain replicated in L-PSGL-1 cells, but
not in L-bsd cells (Fig. 1), which do not express human
PSGL-1, as reported previously (Nishimura et al., 2009).
The viral titres of the original 1095 strain at 0 h and 4 days
post-infection were reduced in the presence of anti-PSGL-1
mAb, but not in the presence of an isotype control (Fig. 1).
These results confirmed that the original 1095 strain
replicated in a PSGL-1-dependent manner, as reported
previously (Nishimura et al., 2009). The viral titres of the
other original EV71 strains in L-PSGL-1 cells were
significantly higher than titres in L-bsd cells 0 h post-
infection, and the viral titres were reduced by anti-PSGL-1
mAb (Fig. 1). These results indicate that original EV71
bound to L-PSGL-1 cells in a PSGL-1-dependent manner.
However, the viral titre of original EV71, except the 1095
strain, remained low in L-PSGL-1 cells even after 4 days
(Fig. 1). On the other hand, all EV71-LPS variants
replicated well in L-PSGL-1 cells, but not in L-bsd cells.
The replication of EV71-LPS variants was inhibited by
anti-PSGL-1 mAb, but not by the isotype control (Fig. 1).
These results indicated that EV71-LPS variants replicated
in L-PSGL-1 cells in a PSGL-1-dependent manner.
To compare viral replication kinetics of the original EV71
and L-PSGL-1-adapted variant in human cells, we infected
Table 1. PSGL-1-binding EV71 strains
Strain (sub-
genogroup)
Major symptom Specimen Cell* Location Year GenBank accession no. Reference
Original LPS variant
1095 (C2) HFMDD Throat swab RD Japan 1997 AB550332 AB550333 Nagata et al. (2002);
Shimizu et al. (2004)
SK-EV006 (B3) Encephalitis (fatal) Rectal swab Vero Malaysia 1997 AB550334 AB550335 Shimizu et al. (1999)
C7/Osaka (B4) Encephalitis (fatal) Stool Vero Japan 1997 AB550336 AB550337 Shimizu et al. (1999)
75-Yamagata (C4) HFMDD Nasopharyngeal
swab
RD Japan 2003 AB550338 AB550339 Mizuta et al. (2005)
KED005 (C1) HFMDD Stool RD Malaysia 1997 AB550340 AB550341 Shimizu et al. (1999)
*The cell line used to prepare the original EV71 strains in this study.
DHand, foot, and mouth disease.
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human peripheral blood mononuclear cells (PBMC;
purchased from Lonza Japan Ltd) with the original 1095
strain or 1095-LPS1 variant. RD (2.5610
4 cells), Jurkat
(4610
4 cells) and human PBMC (2610
5 cells) were
inoculated with viruses of 2.5610
4 (original 1095) or
2.5610
3 (1095-LPS1) CCID50 for 1 h at 37 uC (RD) or on
ice (Jurkat or PBMC), washed and incubated in medium at
37 uC (RD) or 34 uC (Jurkat or PBMC). The original 1095
and 1095-LPS1 strains showed comparable replication
kinetics in RD and Jurkat cells, and both of the EV71
strains did not grow well in human PBMC (Supplementary
Fig. S2, available in JGV Online). We then tested the PSGL-
1-dependent replication competence of other EV71-LPS
variants in Jurkat cells, as described previously (Nishimura
et al., 2009). All five EV71-LPS variants replicated in Jurkat
T cells in a PSGL-1-dependent manner, as demonstrated by
the reduction of viral titres by anti-PSGL-1 mAb blockage
at 3 days post-inoculation (Supplementary Fig. S3, avail-
able in JGV Online). These results indicate that the
phenotypic difference between the original and L-PSGL-
1-adapted EV71 strains was apparent in mouse L-PSGL-1
cells but not in human cells.
Finally, we examined mutations in the genomes of EV71
during the course of replication in L-PSGL-1 cells. We
compared the complete nucleotide and deduced amino
acid sequences between the original EV71 strains and the
EV71-LPS variants. We extracted viral genomic RNA from
the culture fluid of infected cells. We performed RT-PCR
preparation of DNA fragments for DNA sequencing. The
59 and 39 ends of the viral genome were sequenced using
the conventional RACE methods.
1095-LPS1 had two amino acid substitutions at VP2-
K149M and VP3-Y29H compared with the original 1095
strain (Fig. 2). SK-EV006-LPS1 had four nucleotide muta-
tions compared with the original SK-EV006 strain. Three
out of the four mutations changed Y (C or T) to C or T
in the 59 non-translated region (NTR) and the region
encoding non-structural proteins. The other mutation
(A1398T) caused an amino acid substitution at VP2-K149I
(Fig. 2). C7/Osaka-LPS1 and 75-Yamagata-LPS1 had only
one amino acid substitution at VP2-K149 compared with
the corresponding original EV71 strains (Fig. 2). Taken
together, all four EV71-LPS1 variants had an amino acid
substitution at VP2-K149I/M. Although the KED005-LPS2
variant did not have an amino acid substitution in VP2-
K149, it had five amino acid substitutions in VP2 and VP1
(Fig. 2).
Previous studies have shown that the expression of specific
cellular receptors for human enteroviruses on the cell
surface of rodent cells allows effective viral replication
similar to that in human susceptible cells expressing the
corresponding viral receptors [human poliovirus receptor
(Mendelsohn et al., 1989), human intercellular adhesion
molecule-1 (Shafren et al., 1997), and human coxsacki-
evirus and adenovirus receptor (Bergelson et al., 1997)].I n
the case of EV71, mouse L929 cells expressing human
SCARB2 exhibit high susceptibility to EV71, which is
comparable to human RD cells (Yamayoshi et al., 2009).
These results suggest that the efficacy of replication of
enteroviruses, including EV71, mainly depends on the
Fig. 1. EV71 replication in L-PSGL-1 cells in the presence of a
PSGL-1-specific mAb. L-bsd cells were used as a PSGL-1-
negative control.
EV71 replication in L-PSGL-1 cells
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rodent cell lines that are naturally non-permissive for
enterovirus infection. In other words, after virus binding,
entry and uncoating steps, which may be facilitated by
virus-receptor interactions, rodent cells may support
efficient viral replication of human enteroviruses.
On the other hand, not only the binding capability of the
EV71 strains to PSGL-1, but also an adaptive mutation(s)
in the capsid proteins was required for efficient viral
replication of PSGL-1-binding strains of EV71 in L-PSGL-1
cells. A previous study using infectious molecular clones of
EV71 revealed that a mutation at VP2-K149I is critical for
efficient virus replication in Chinese hamster ovary cells
(Chua et al., 2008). In addition, one of the adaptive
mutations was identified at VP2-K149 during the course of
in vivo adaptation of EV71 by serial passaging of the virus
in mouse brain (Wang et al., 2004). Furthermore, a mouse-
adapted EV71 variant (Nagoya-2876A strain) derived from
a cDNA of the Nagoya strain of EV71 contains Ile at VP2-
149 instead of the Lys residue that is conserved among
other EV71 strains (Arita et al., 2008). These results suggest
that an amino acid substitution at VP2-K149 plays a
critical role in the in vitro and in vivo adaptation of EV71 in
rodent cells. Like human fibroblast cell lines, mouse L929
cells do not express detectable levels of mouse PSGL-1
(Thomas et al., 2009). Therefore, mouse-adaptive muta-
tions in the capsid proteins of EV71 may not be directly
associated with a phenotypic change in EV71 variants with
receptor-binding capability to mouse PSGL-1. For mouse-
adapted poliovirus variants, some of the mouse adaptation
determinants in the capsid proteins involve the efficacy of
viral uncoating (Couderc et al., 1996) and the others might
be responsible for binding of the mutants to unidentified
mouse receptor (Murray et al., 1988). Likewise, it remains
uncertain whether a mutation at VP2-K149 of EV71 is
responsible for the change in tropism in a receptor-
dependent or -independent manner.
Four out of five LPS variants, including 1095-LPS,
contained an amino acid substitution at VP2-K149 after
a single passage of the original EV71 strains in L-PSGL-1
cells. The VP2-K149 substitution confers only one amino
acid difference between the original EV71 strains and the
LPS variants of the C7/Osaka and 75-Yamagata strains,
suggesting that the single amino acid at VP2-149 is a
potential determinant for the adaptation phenotype of
EV71 to L-PSGL-1 cells. For the KED005-LPS2 variant, an
amino acid change at VP2-K149 was not identified, but
instead, multiple amino acid substitutions (three in VP2
and two in VP1) were found after a second passage in L-
PSGL-1 cells. Further analysis using infectious clones of
EV71 will be required to elucidate the contribution of
possible determinants for adaptation to mouse cells.
Mouse L929 cell lines expressing the human poliovirus
receptor have played a critical role in laboratory diagnosis
of polioviruses for global polio eradication (Hovi &
Fig. 2. Schematic of mutations identified in
EV71-LPS1 (1095, SK-EV006, C7/Osaka and
75-Yamagata) and EV71-LPS2 (KED005) com-
pared with the corresponding original EV71
strains. Amino acid substitutions observed in
EV71-LPS are shown as black stars and VP2-
149 are indicated as grey stars. A synonymous
mutationand a mutation in the 59 NTRare shown
aswhitestars.TheaminoacidXindicatesthatits
codon contains mixed nucleotides.
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expressing specific cellular receptors for EV71, PSGL-1
and SCARB2, may also be useful for receptor-specific
isolation and identification of EV71 from clinical samples
(Nishimura et al., 2009; Yamayoshi et al., 2009). However,
as we have shown in this study, along with the PSGL-1-
binding phenotype of EV71, the adaptation and selection
bias among EV71 variants to grow in L-PSGL-1 cells
should be carefully considered. Likewise, the mouse-
adaptive phenotype of the EV71 strains and variants
should also be taken into account when establishing
transgenic mouse models carrying human receptors for
EV71.
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